Showing results (251-260 of 265) with videos related to

Sort By:
Pageof 27
ESMO Open|February 26, 2022
Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatmentP Conte, P A Ascierto, G Patelli, et al.
ESMO Open|June 11, 2025
Clinical relevance and methodological approach for the assessment of drug-drug interactions in cancer patients: a position statement from the Italian Association of Medical Oncology (AIOM) and the Italian Society of Pharmacology (SIF)M Del Re, R Roncato, A Argentiero, et al.
British Journal of Cancer|March 17, 2011
Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancerF Loupakis, C Cremolini, A Fioravanti, et al.
ESMO Open|September 12, 2021
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patientsM Del Re, C Omarini, L Diodati, et al.
The Pharmacogenomics Journal|November 11, 2009
Expression of gemcitabine- and cisplatin-related genes in non-small-cell lung cancerF Toffalorio, E Giovannetti, T De Pas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2011
An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patientsF Crea, L Fornaro, E Paolicchi, et al.
The Pharmacogenomics Journal|March 5, 2014
The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemiaA Di Paolo, M Polillo, M Capecchi, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsyR Minari, P Bordi, M Del Re, et al.
ESMO Open|May 13, 2021
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paperN Silvestris, A Argentiero, A Natalicchio, et al.
ESMO Open|May 21, 2021
Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paperM Gallo, V Adinolfi, L Morviducci, et al.
Pageof 27